Kalshi Extends Bets to Drug Trials and Regulatory Outcomes
TL;DR Summary
Kalshi is piloting bets on drug-trial results and FDA regulatory decisions (in partnership with AppliedXL) to surface publicly updated trial probabilities and improve information flow, with safeguards like employment verification; it’s also evaluating a separate flight-cancellation contract, signaling ongoing growth in prediction markets despite scrutiny over manipulation.
- Kalshi to offer betting on drug trial results and FDA regulatory decisions The Guardian
- Kalshi Will Offer Sports-Style Betting on Drug Trial Results Bloomberg.com
- Kalshi comes for biopharma, with prediction markets for clinical trials and FDA approvals STAT
- Kalshi Is Letting People Bet On Clinical Trials And FDA Drug Decisions Forbes
- Kalshi to allow bets on clinical trials, FDA decisions Reuters
Reading Insights
Total Reads
1
Unique Readers
33
Time Saved
3 min
vs 3 min read
Condensed
92%
589 → 47 words
Want the full story? Read the original article
Read on The Guardian